ICON plc is a leading provider of digital solutions designed to enhance the efficiency of clinical trials and drive site performance. With a comprehensive range of products and services, ICON offers solutions that cover the entire lifecycle of product development and commercialization. Their offerings can be tailored to meet the needs of both small local trials and large global programs.

From clinical and scientific operations consulting to language services and strategic solutions, ICON provides end-to-end services, operational models, and cutting-edge technology to deliver customized solutions. They also specialize in real-world intelligence, leveraging real-world data to drive effective outcomes and achieve regulatory authorizations. With expertise in various industry sectors, including biosimilars, biotech, government and public health, medical device, and pharmaceuticals, ICON is dedicated to partnering with clients to make a difference in the development of transformative therapies.

With extensive experience in a wide range of therapeutic areas, ICON has established solid working relationships with leading investigators worldwide. Their expertise spans from cardiovascular and infectious diseases to women's health and vaccines, where they have played a pivotal role in the development and FDA/EMA approvals of 18 vaccines